IGPS

Welcome to the Brand page for “IGPS”, which is offered here for Pharmaceutical, medical and clinical preparations for use in cell and gene therapy; pharmaceutical, medical and clinical preparations for use in cell and gene therapy for treatment of cancer and genetic diseases; cell and gene therapy vectors for treatment of cancer and genetic diseases; therapeutic preparations for enhancing the targeting, delivery, and effectiveness of cancer treatments; t-cells for medical and therapeutic use; cell-based immunotherapeutic treatment by way of genetically modified cells for use in human therapeutics and the treatment of cancer and genetic diseases; pharmaceutical and biological preparations based on gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy for use in human therapeutics, therapeutic pharmaceuticals developed through genome modifications for the treatment of cancer and genetic diseases;scientific and medical research services in the field of cell and gene therapies; scientific and medical research services in the field of cell and gene therapies using engineered viral vectors;.

Its status is currently believed to be active. Its class is unavailable. “IGPS” is believed to be currently owned by “KELONIA THERAPEUTICS, INC.”